Temozolomide

• Description:

  A DNA methylating agent. A second-generation imidazotetrazine prodrug that undergoes spontaneous conversion under physiological conditions to the active alkylating agent MTIC (3-methyl-(triazen-1-yl)imidazole-4-carboxamide). Displays antitumor activity against a board spectrum of tumors, including leukemias, lymphomas and solid tumors.

• Shipping Conditions:

  gel pack

• Storage Conditions:

  -20°C

• Shelf Life:

  24 months